| pubmed-article:7889455 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7889455 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
| pubmed-article:7889455 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
| pubmed-article:7889455 | lifeskim:mentions | umls-concept:C0004259 | lld:lifeskim |
| pubmed-article:7889455 | lifeskim:mentions | umls-concept:C0014277 | lld:lifeskim |
| pubmed-article:7889455 | lifeskim:mentions | umls-concept:C0015846 | lld:lifeskim |
| pubmed-article:7889455 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:7889455 | lifeskim:mentions | umls-concept:C1521801 | lld:lifeskim |
| pubmed-article:7889455 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:7889455 | pubmed:dateCreated | 1995-4-17 | lld:pubmed |
| pubmed-article:7889455 | pubmed:abstractText | Cardiovascular effects of high dose opioid together with low dose inhalant were compared with inhalant alone to determine whether opioid/inhalant techniques were less depressant on the cardiovascular system. The effects of positive pressure ventilation and increasing heart rate to a more physiological level were also studied. Cardiovascular measurements recorded during administration of enflurane at 1.3 minimum alveolar concentration (MAC; 2.89 +/- 0.02%) to spontaneously breathing dogs (time 1) and during controlled ventilation [arterial carbon dioxide tension at 40 +/- 3 mmHg (time 2)] were similar. At time 2, mixed venous oxygen tension and arterial and mixed venous carbon dioxide tensions were significantly decreased, while arterial and mixed venous pH were significantly increased compared to measurements at time 1. After administration of fentanyl to achieve plasma fentanyl concentration of 71.7 +/- 14.4 ng/mL and reduction of enflurane concentration to yield 1.3 MAC multiple (0.99 +/- 0.01%), heart rate significantly decreased, while mean arterial pressure, central venous pressure, stroke index, and systemic vascular resistance index increased compared to measurements taken at times 1 and 2. Pulmonary arterial occlusion pressure was significantly increased compared to measurements taken at time 2. After administration of atropine until heart rate was 93 +/- 5 beats/min (plasma fentanyl concentration 64.5 +/- 13.5 ng/mL) heart rate, mean arterial pressure, cardiac index, oxygen delivery index, and venous admixture increased significantly compared to values obtained at all other times.(ABSTRACT TRUNCATED AT 250 WORDS) | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7889455 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7889455 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7889455 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7889455 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:7889455 | pubmed:issn | 0830-9000 | lld:pubmed |
| pubmed-article:7889455 | pubmed:author | pubmed-author:HaskinsS CSC | lld:pubmed |
| pubmed-article:7889455 | pubmed:author | pubmed-author:IlkiwJ EJE | lld:pubmed |
| pubmed-article:7889455 | pubmed:author | pubmed-author:JaffeRR | lld:pubmed |
| pubmed-article:7889455 | pubmed:author | pubmed-author:PatzJ DJD | lld:pubmed |
| pubmed-article:7889455 | pubmed:author | pubmed-author:PascoeP JPJ | lld:pubmed |
| pubmed-article:7889455 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7889455 | pubmed:volume | 58 | lld:pubmed |
| pubmed-article:7889455 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7889455 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7889455 | pubmed:pagination | 248-53 | lld:pubmed |
| pubmed-article:7889455 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:7889455 | pubmed:meshHeading | pubmed-meshheading:7889455-... | lld:pubmed |
| pubmed-article:7889455 | pubmed:meshHeading | pubmed-meshheading:7889455-... | lld:pubmed |
| pubmed-article:7889455 | pubmed:meshHeading | pubmed-meshheading:7889455-... | lld:pubmed |
| pubmed-article:7889455 | pubmed:meshHeading | pubmed-meshheading:7889455-... | lld:pubmed |
| pubmed-article:7889455 | pubmed:meshHeading | pubmed-meshheading:7889455-... | lld:pubmed |
| pubmed-article:7889455 | pubmed:meshHeading | pubmed-meshheading:7889455-... | lld:pubmed |
| pubmed-article:7889455 | pubmed:meshHeading | pubmed-meshheading:7889455-... | lld:pubmed |
| pubmed-article:7889455 | pubmed:meshHeading | pubmed-meshheading:7889455-... | lld:pubmed |
| pubmed-article:7889455 | pubmed:meshHeading | pubmed-meshheading:7889455-... | lld:pubmed |
| pubmed-article:7889455 | pubmed:meshHeading | pubmed-meshheading:7889455-... | lld:pubmed |
| pubmed-article:7889455 | pubmed:meshHeading | pubmed-meshheading:7889455-... | lld:pubmed |
| pubmed-article:7889455 | pubmed:meshHeading | pubmed-meshheading:7889455-... | lld:pubmed |
| pubmed-article:7889455 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7889455 | pubmed:articleTitle | The cardiovascular sparing effect of fentanyl and atropine, administered to enflurane anesthetized dogs. | lld:pubmed |
| pubmed-article:7889455 | pubmed:affiliation | Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis 95616. | lld:pubmed |
| pubmed-article:7889455 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7889455 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7889455 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7889455 | lld:pubmed |
